Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
Fei Li, Zaosong Zheng, Wei Chen, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100938-100938
Closed Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer
Fei Li, Henghui Zhang, Yu‐An Huang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101059-101059
Closed Access | Times Cited: 29
Exosomal circRNAs: Novel biomarkers and therapeutic targets for urinary tumors
Qiang Liu, Shenglong Li
Cancer Letters (2024) Vol. 588, pp. 216759-216759
Closed Access | Times Cited: 12
Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer
Yiyang Wang, Yongxiang Li, Yubo Jing, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
RNA methylation‐related inhibitors: Biological basis and therapeutic potential for cancer therapy
Huanxiang Chen, Hongyang Liu, Chenxing Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 6
Combating cisplatin-resistant lung cancer using a coiled-coil lipopeptides modified membrane fused drug delivery system
Xi Wang, G. Liu, Xueyu Pu, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 45-58
Closed Access
Non-Coding RNAs in Urinary Bladder Cancer Microenvironment: Diagnostic, Therapeutic, and Prognostic Perspective
Enas A. El Saftawy, Basma Emad Aboulhoda, Marwa Ali Abd Elkhalek, et al.
Pathology - Research and Practice (2025) Vol. 266, pp. 155815-155815
Closed Access
Histone lactylation regulates PRKN-Mediated mitophagy to promote M2 Macrophage polarization in bladder cancer
Xiaolin Deng, Yuan Huang, Jin-Ge Zhang, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114119-114119
Closed Access
Mechanisms behind the LncRNAs-mediated regulation of paclitaxel (PTX) resistance in human malignancies
Ali G. Alkhathami, Harikumar Pallathadka, Sejal Shah, et al.
Experimental Cell Research (2025), pp. 114434-114434
Closed Access
Epigenetic and Immunological Features of Bladder Cancer
I. R. Gilyazova, Kadriia Enikeeva, Guzel Rafikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9854-9854
Open Access | Times Cited: 15
miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment
Tingxuan Wang, Jincheng Huang, Gang Chen, et al.
International Immunopharmacology (2024) Vol. 130, pp. 111702-111702
Closed Access | Times Cited: 5
Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance
Meng Wang, Guimei Li, Guiyang Jiang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6218-6237
Closed Access | Times Cited: 5
PTBP1-mediated biogenesis of circATIC promotes progression and cisplatin resistance of bladder cancer
Chenchen Huang, Yang Yang, Xiaofei Wang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3570-3589
Open Access | Times Cited: 5
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells
Wentao Mu, Zhi Yao, Jianpeng Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Epigenetic regulation of DNA repair gene program by Hippo/YAP1-TET1 axis mediates sorafenib resistance in HCC
Chunli Mo, Weixin You, Y. V. N. Rao, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer
Jitendra Gupta, Abdulrahman T. Ahmed, Nahla A. Tayyib, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115337-115337
Open Access | Times Cited: 10
Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis
Jie Chen, Di Zhao, Lingyuan Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101055-101055
Closed Access | Times Cited: 3
Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis
Lan Hong, Xiuzhen Wang, Lang Zheng, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 1, pp. 71-81
Open Access | Times Cited: 9
SIRT1 Promotes Cisplatin Resistance in Bladder Cancer via Beclin1 Deacetylation-Mediated Autophagy
Yan Sun, Xudong Liu, Hang Tong, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 125-125
Open Access | Times Cited: 9
Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance
Meiying Qin, Chunmei Zhang, Li Yang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in bladder cancer
Peng Li, Weihua Wang, Zhu Baowei, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 5, pp. 2869-2880
Open Access | Times Cited: 2
Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin Sensitivity in Bladder Cancer
Miner Xie, Liwen Zhou, Ting Li, et al.
Advanced Science (2024) Vol. 11, Iss. 22
Open Access | Times Cited: 2
Effects and mechanisms of N6-methyladenosine RNA methylation in environmental pollutant-induced carcinogenesis
Tong‐Fei Li, Zhijie Xu, Kui Zhang, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 277, pp. 116372-116372
Open Access | Times Cited: 2
Integrated analysis of multiple transcriptomic approaches and machine learning integration algorithms reveals high endothelial venules as a prognostic immune-related biomarker in bladder cancer
Jin-Ge Zhang, Yuan Huang, Xing Tan, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112184-112184
Closed Access | Times Cited: 2
The clinical value of rapidly detecting urinary exosomal lncRNA RMRP in bladder cancer with an RT-RAA-CRISPR/Cas12a method
Yuting Gao, Xueru Zhang, Xuanlin Wang, et al.
Clinica Chimica Acta (2024) Vol. 562, pp. 119855-119855
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top